Franck Talmont

Prof. Franck Talmont

IPBS-CNRS
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2006 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
VSV. Sarramegn
V. Sarramegn
IMI. Muller
I. Muller
AMA. Milon
A. Milon
Franck TalmontFranck Talmont
Franck Talmont

25 September 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MBMarie Beaurain
Marie Beaurain
ASAnne-Sophie Mme SALABERT
Anne-Sophie Mme SALABERT
PPPierre Payoux
Pierre Payoux
EGEmmanuel Gras
Emmanuel Gras
Franck TalmontFranck Talmont
Franck Talmont
Background: N-methyl-D-aspartate receptors (NMDARs) are members of the ionotropic glutamate receptor family. These ligand-gated channels are entwined with numerous fundamental neurological functions within the central nervous system (CNS), and numerous neuropsychiatric disorders may arise from their malfunction. Methods: The purpose of the present review is to provide a detailed description of NMDARs by addressing their molecular structures, activation mechanisms, and physiological roles in the mammalian brain. In the second part, their role in various neuropsychiatric disorders including stroke, epilepsy, anti-NMDA encephalitis, Alzheimer’s and Huntington’s diseases, schizophrenia, depression, neuropathic pain, opioid-induced tolerance, and hyperalgesia will be covered. Results: Finally, through a careful exploration of the main non-competitive NMDARs antagonists (channel-blockers). Conclusion: We discuss the strengths and limitations of the various molecular structures developed for diagnostic or therapeutic purposes.

29 June 2006 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
VSV. Sarramegna
V. Sarramegna
IMI. Muller
I. Muller
AMA. Milon
A. Milon
Franck TalmontFranck Talmont
Franck Talmont

1 May 2008 in The Journal of Membrane Biology
Verified
Journal Article
Closed access
PDF file
IMIsabelle Muller
Isabelle Muller
VSValérie Sarramégna
Valérie Sarramégna
MRMarie Renault
Marie Renault
VLVincent Lafaquière
Vincent Lafaquière
SSSarra Sebai
Sarra Sebai
Franck TalmontFranck Talmont
Franck Talmont

21 December 2023 in Bioelectrochemistry
Verified
Journal Article
Closed access
ACAlexia de Caro
Alexia de Caro
Franck TalmontFranck Talmont
Franck Talmont
Marie-Pierre RolsMarie-Pierre Rols
Marie-Pierre Rols
MGMuriel Golzio
Muriel Golzio
JKJelena Kolosnjaj-Tabi
Jelena Kolosnjaj-Tabi

27 September 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Franck TalmontFranck Talmont
Franck Talmont
LMLionel Moulédous
Lionel Moulédous
JBJérôme Boué
Jérôme Boué
CMCatherine Mollereau
Catherine Mollereau
GDGilles Dietrich
Gilles Dietrich
G-protein coupled receptors (GPCRs) play a major role in a number of physiological and pathological processes. Thus, GPCRs have become the most frequent targets for development of new therapeutic drugs. In this context, the availability of highly specific antibodies may be decisive to obtain reliable findings on localization, function and medical relevance of GPCRs. However, the rapid and easy generation of highly selective anti-GPCR antibodies is still a challenge. Herein, we report that highly specific antibodies suitable for detection of GPCRs in native and unfolded forms can be elicited by immunizing animals against purified full length denatured recombinant GPCRs. Contrasting with the currently admitted postulate, our study shows that an active and well-folded GPCR is not required for the production of specific anti-GPCR antibodies. This new immunizing strategy validated with three different human GPCR (μ-opioid, κ-opioid, neuropeptide FF2 receptors) might be generalized to other members of the GPCR family.